Evaluation of sorafenib for advanced hepatocellular carcinoma with low α-fetoprotein in arrival time parametric imaging using contrast-enhanced ultrasonography
ConclusionsThe results suggested that AtPI was useful for evaluating early response to sorafenib for advanced HCC with low AFP level.
Source: Journal of Medical Ultrasonics - Category: Radiology Source Type: research
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver Cancer | Radiology | Statistics | Study